Oral contraceptives and cardiovascular disease: Some questions and answers

British Medical Journal (Clinical research ed.)

Volumn 284, Issue 6316, 1982, Pages 615-616

  Vessey, Mp ^a  

^a RADCLIFFE INFIRMARY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ORAL CONTRACEPTIVE AGENT;

ADVERSE DRUG REACTION; AGE; BLOOD AND HEMOPOIETIC SYSTEM; CARDIOVASCULAR DISEASE; CARDIOVASCULAR SYSTEM; EDITORIAL; EMBOLISM; HEART; HEART DISEASE; ORAL DRUG ADMINISTRATION; SMOKING; THROMBOSIS;

ADULT; CARDIOVASCULAR DISEASES; CONTRACEPTIVES, ORAL; FEMALE; HUMAN; RISK; SMOKING; SUBARACHNOID HEMORRHAGE; THROMBOPHLEBITIS;

EID: 0020047267     PISSN: 02670623     EISSN: None     Source Type: Journal    
DOI: 10.1136/bmj.284.6316.615     Document Type: Editorial

References (24)

1. Vessey MP. Female hormones an,d vascular disease—an epidemiological overview. British Journal of Family Planning 1980;6, suppl:1–12.
2. Stadel BV. Oral contraceptives and cardiovascular disease. (First of two: parts.) N Engl J Med 1981;305:612–8.
3. Stadel BV. Oral contraceptives and cardiovascular disease. (Second of two parts.) N Engl J Med 1981;305:672–7.
4. Shearman RP. Oral contraceptives: where are the excess deaths ? Med J Aust 1981;i:698–700.
5. Tietze C. The pill and mortality from cardiovascular disease: another look. Fam Plann Perspect 1979;11:80–4.
6. Betsey MA, Russell Y, Kinnear K. Cardiovascular disease and oral contraceptives: a reappraisal of vital statistics data. Fam Plann Perspect 1979; 11:84–9.
7. Wiseman RA, MacRae KD. Oral contraceptives and the decline in mortality from circulatory disease. Fertil Steril 1981;35:277–83.
8. Mann J I, Vessey MP. Trends in cardiovascular disease mortality and oral contraceptives. British Journal of Family Planning 1981;6:99–104.
9. Adam SA, Thorogood M, Mann JI. Oral contraception and myocardial infarction revisited: the effects-of new preparations and prescribing patterns. Br J Obstet Gynaecol. 1981;88:838–45.
10. Mann JI, Doll R, Thorogood M, Vessey MP, Waters WE. Risk factors for myocardial infarction in young women. British Journal of Preventive and Social Medicine 1976;30:94–100.
11. Shapiro S, Slone D, Rosenberg L, Kaufman DW, Stolley PD, Miettinen OS. Oral-contraceptive use in relation to myocardial infarction. Lancet 1979;i:743–6,7.
12. Royal College of General Practitioners’ Oral Contraception Study. Further analyses of mortality in oral contraceptive users. Lancet 1981;i:541–6.
13. Lawson DH, Davidson JF, Jick H. Oral contraceptive use and venous thromboembolism: absence of an effect of smoking. Br Med J 1977;ii:729–30.
14. Goldzieher JW. Oral contraceptive hazards—1981. Fertil Steril 1981;35:275–6.
15. Barnes RW, Krapf T, Hoak JC. Erroneous clinical diagnosis of leg vein thrombosis in women on oral contraceptives. Obstet Gynecol 1978;51:556-8
16. Tibbut D. Thrombosis statistics. Br Med J 1977;i: 231.
17. Vessey MP, Doll R. Investigation of relation between use of oral contraceptives and thromboembolic disease. A further report. Br Med J 1969;ii:65l–7.
18. Vessey MP. Some methodological problems in the investigation of rare adverse reactions to oral contraceptives. Am J Epidemiol 1971;94:202–9.
19. Collaborative Group for the Study of Stroke in Young Women. Oral contraception and increased risk of cerebral ischemia or thrombosis. N Engl J Med 1973;288:871–8.
20. Inman WHW. Oral contraceptives and fatal subarachnoid haemorrhage. Br Med J 1979;ii:1468–70.
21. Thorogood M, Adam SA, Mann JI. Fatal subarachnoid haemorrhage in young women: role of oral contraceptives, Br Med J 1981;283:762.
22. Slone D, Shapiro S, Kaufman DW, Rosenberg L, Miettinen OS, Stolley PD. Risk of myocardial infarction in relation to current and discontinued use of oral contraceptives. N Engl J Med 1981;305:420–4.
23. Pettiti DB, Wingerd J. Use of oral contraceptives, cigarette smoking, and risk of subarachnoid liaemorrhage. Lancet 1978;ii:234–5, 6.
24. Vessey MP, McPherson K, Yeates D. Mortality in oral contraceptive users. Lancet 1981;i:549–50.